Novozymes A/S
NVZMY | OTC
$69.19
+$0.13 (+0.18%)
Nov 2, 2026, 12:37 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.3B | 4.2B | 4.16B | 4.14B | 4.08B | 4.04B | 3.81B | 4.05B | 3.64B | 3.23B | 7B | 10.31B | 14.09B | 17.81B | 17.55B | 16.86B | 16.25B | 15.55B | 14.95B | 14.56B | 14.23B | 14B |
Cost of Revenue | 1.94B | 1.92B | 1.92B | 1.97B | 1.83B | 1.93B | 1.94B | 2.01B | 1.9B | 1.58B | 3.21B | 4.75B | 6.5B | 8.15B | 7.98B | 7.56B | 7.12B | 6.69B | 6.33B | 6.18B | 6.1B | 6.11B |
Gross Profit | 2.36B | 2.28B | 2.24B | 2.18B | 2.25B | 2.1B | 1.87B | 2.03B | 1.74B | 1.65B | 3.79B | 5.56B | 7.59B | 9.65B | 9.58B | 9.3B | 9.13B | 8.85B | 8.62B | 8.39B | 8.13B | 7.89B |
Operating Income | 913.04M | 875.69M | 882.97M | 884.17M | 867.36M | 756.64M | 547.68M | 672.73M | 626.49M | 633.55M | 1.7B | 2.48B | 3.63B | 4.62B | 4.63B | 4.34B | 4.15B | 4.03B | 4.01B | 4B | 3.8B | 3.67B |
Interest Income | 20.99M | 20.99M | 20.99M | 20.99M | n/a | n/a | n/a | n/a | 11M | 11M | 11M | 11M | n/a | n/a | n/a | 116M | 116M | 116M | 116M | n/a | n/a | n/a |
Pretax Income | 802.98M | 755.93M | 743.72M | 698.85M | 690.39M | 558.83M | 361.18M | 531.36M | 521.43M | 585.63M | 1.58B | 2.35B | 3.58B | 4.52B | 4.56B | 4.28B | 3.95B | 3.89B | 3.92B | 3.96B | 3.79B | 3.61B |
Net Income | 631.82M | 596.95M | 583.84M | 547.27M | 529.82M | 423.58M | 270.92M | 404.09M | 408.38M | 459.19M | 1.21B | 1.87B | 2.9B | 3.63B | 3.68B | 3.42B | 3.11B | 3.09B | 3.15B | 3.18B | 3.04B | 2.9B |
Selling & General & Admin | 969.05M | 944.7M | 912.1M | 872.42M | 845.27M | 816.86M | 772.01M | 777.88M | 677.52M | 596.49M | 1.32B | 1.91B | 2.6B | 3.28B | 3.19B | 3.26B | 3.12B | 2.96B | 2.8B | 2.51B | 2.42B | 2.33B |
Research & Development | 366.96M | 356.68M | 463.95M | 446.46M | 436.93M | 430.12M | 414.39M | 435.78M | 388.12M | 354.48M | 779.94M | 1.18B | 1.6B | 2.03B | 2B | 1.98B | 1.94B | 1.94B | 2.01B | 2.03B | 2.07B | 2.04B |
Other Expenses | 110.27M | 105.17M | -16.7M | -24.6M | 96.75M | 99.06M | 139.93M | 148.02M | 49.98M | 70.37M | -7.51M | -5.61M | -234.41M | -271M | -245M | -278M | -79M | -79M | -188M | -153M | -151M | -154M |
Operating Expenses | 1.45B | 1.41B | 1.36B | 1.29B | 1.38B | 1.35B | 1.33B | 1.36B | 1.12B | 1.02B | 2.09B | 3.08B | 3.96B | 5.03B | 4.95B | 4.96B | 4.98B | 4.82B | 4.62B | 4.39B | 4.34B | 4.22B |
Interest Expense | 84.07M | 69.87M | 80.57M | 81.87M | 71.99M | 80.77M | 80.36M | 88.27M | 69.36M | 82.88M | 90M | 117M | 127M | 100M | 84M | 31M | 30M | 31M | 31M | 44M | 50M | 50M |
Selling & Marketing Expenses | 737.94M | 720.06M | 688.81M | 647.64M | 616.98M | 590.33M | 558.4M | 557.02M | 482.73M | 424.53M | 941.51M | 1.35B | 1.82B | 2.29B | 2.24B | 2.29B | 2.2B | 2.08B | 1.94B | 1.72B | 1.65B | 1.59B |
Cost & Expenses | 3.39B | 3.33B | 3.28B | 3.26B | 3.21B | 3.28B | 3.26B | 3.37B | 3.01B | 2.6B | 5.3B | 7.84B | 10.46B | 13.18B | 12.92B | 12.51B | 12.1B | 11.51B | 10.94B | 10.57B | 10.44B | 10.33B |
Income Tax Expense | 171.17M | 158.98M | 159.87M | 151.58M | 160.56M | 135.25M | 90.26M | 128.68M | 115.38M | 127.7M | 353.01M | 461.01M | 666.71M | 872M | 870M | 850M | 826M | 795M | 779M | 783M | 749M | 712M |
Shares Outstanding (Basic) | 466.25M | 466.23M | 414.56M | 414.56M | 471.72M | 465M | 456.42M | 483.81M | 510M | 416.25M | 274.13M | 277M | 277M | 276.9M | 276.47M | 276.3M | 277M | 277.1M | 277.51M | 277.1M | 278.3M | 279.2M |
Shares Outstanding (Diluted) | 466.25M | 466.23M | 472.31M | 472.31M | 471.72M | 468.1M | 456.42M | 484.8M | 510M | 435.2M | 277.59M | 277.7M | 277.9M | 277.8M | 278.57M | 278.4M | 279.4M | 279.5M | 279.86M | 279.8M | 280.7M | 280.9M |
EPS (Basic) | 1.40 | 1.32 | 1.29 | 1.18 | 1.13 | 0.90 | 0.58 | 1.19 | 1.39 | 1.62 | 4.37 | 6.76 | 10.48 | 13.11 | 13.28 | 12.34 | 11.21 | 11.14 | 11.31 | 11.40 | 10.90 | 10.35 |
EPS (Diluted) | 1.36 | 1.28 | 1.25 | 1.18 | 1.13 | 0.90 | 0.58 | 1.18 | 1.38 | 1.61 | 4.35 | 6.73 | 10.42 | 13.03 | 13.19 | 12.25 | 11.12 | 11.05 | 11.22 | 11.31 | 10.83 | 10.28 |
EBITDA | 1.72B | 1.5B | 1.35B | 1.35B | 926.13M | 803.35M | 653.66M | 1.2B | 1.34B | 1.72B | 3.16B | 3.98B | 4.89B | 5.88B | 5.41B | 6.02B | 5.69B | 5.26B | 5.63B | 5.41B | 5.25B | 5.06B |
EBIT | 839.29M | 772.34M | 770.82M | 779.72M | 889.6M | 766.83M | 617.14M | 795.24M | 643.98M | 688.8M | 1.77B | 2.59B | 3.83B | 4.78B | 4.66B | 4.37B | 4.03B | 3.98B | 4.01B | 3.91B | 3.74B | 3.56B |
Depreciation & Amortization | 882.29M | 724.71M | 575.05M | 575.05M | 36.52M | 36.52M | 36.52M | 401.52M | 697M | 1.03B | 1.39B | 1.39B | 1.06B | 1.1B | 747M | 1.65B | 1.65B | 1.28B | 1.62B | 1.5B | 1.5B | 1.5B |
Add to Watchlist
Select watchlists to add or remove NVZMY